Cystic Fibrosis Clinical Trials

Find Cystic Fibrosis Clinical Trials Near You

Exploring a Common Genetic Risk Factor for Heat Stroke and Dehydration

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

The goal of this observational study is to examine the effect of the Cystic Fibrosis (CF) Carrier state on the risk for dehydration and other CF-specific fluid-and-electrolyte disorders in male and female adults. The primary aim of the study is to estimate the risk of electrolyte disorders attributable to the CF carrier state in a genotyped cohort. This will be accomplished with two smaller projects- Aim 1 and Aim 2. Aim 1 will consist of 100 CF Carriers and 100 age- and sex-matched controls. Participants in this aim will be asked to complete a Participant Info and Temperature Survey consisting of questions about race, ethnicity, medical history, and how they experience heat. Aim 2 will consist of a subset of 25 CF Carriers and 25 age- and sex-matched controls from Aim 1. Participants in this aim will be scheduled for a visit to complete a heat challenge. At this visit, they will also complete the Participant Info and Temperature Survey. They will also sit in a sauna at 62 - 63 degrees Celsius for 45 minutes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• Previously genotyped as a CF carrier or control

• Comfortable speaking/reading English

Locations
United States
Iowa
University of Iowa Health Care
RECRUITING
Iowa City
Contact Information
Primary
Aaron Miller, PhD
aaron-miller@uiowa.edu
(319) 335-3053
Backup
Shelby L Francis, PhD
shelby-francis@uiowa.edu
319-678-8037
Time Frame
Start Date: 2025-11-19
Estimated Completion Date: 2026-03
Participants
Target number of participants: 200
Treatments
CF Carriers
Participants who have previously been genotyped as CF Carriers.
Controls
Participants who have previously been genotyped as controls and are age- and sex-matched to a CF Carrier.
Related Therapeutic Areas
Sponsors
Leads: University of Iowa

This content was sourced from clinicaltrials.gov